Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI

Trial Profile

Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis IV
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Aug 2017 Status changed from recruiting to completed.
    • 20 May 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 14 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top